🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Epidermolysis bullosa simplex (EBS) is a rare genetic skin disease characte...
Status
Terminated
Location
Phoenix Childrens Hospital
Start Date
2017-06-01
Trial ID
NCT03154333
Treatments Being Tested
This study is being conducted to characterize the mechanism of action of cr...
Status
Completed
Location
Innovaderm Research Incorporated
Start Date
2017-07-31
Trial ID
NCT03233529
Treatments Being Tested
This Phase III study is designed to evaluate the efficacy and safety of KX2...
Status
Completed
Location
Coastal Clinical Research, Inc.
Start Date
2017-09-18
Trial ID
NCT03285477
Treatments Being Tested
The study is beng done to test if tofacitinib ointment is safe and effectiv...
Status
Completed
Location
Burke Pharmaceutical Research
Start Date
2013-05
Trial ID
NCT01831466
Randomized, Vehicle-controlled, Parallel Group Study of TDM-180935 in Atopi...
Status
Completed
Location
Site 5
Start Date
2024-04-13
Trial ID
NCT06363461
The purpose of this study is to evaluate the efficacy and safety of two dos...
Status
Completed
Location
Clinical Research Site
Start Date
2004-09
Trial ID
NCT00373516
The purpose of this study is to determine the safety and efficacy of three ...
Status
Completed
Location
PAREXEL International (Bloemfontein)
Start Date
2009-07-15
Trial ID
NCT00944632
Treatments Being Tested
The aim of this trial is to assess the efficacy of 0417 Ointment in the Tre...
Status
Completed
Location
Fougera Pharmaceuticals Inc.
Start Date
2008-01
Trial ID
NCT01139450
Treatments Being Tested
The objective of the study is to compare the healing of wounds induced by c...
Status
Completed
Location
Dept. of Dermatology, Wake Forrest School of Medicine
Start Date
2008-06
Trial ID
NCT00713349
Treatments Being Tested
This study will evaluate the use of topical 5 or 10% sinecatechins, a botan...
Status
Terminated
Location
Lila Nachtigall, M.D.
Start Date
2018-08-30
Trial ID
NCT03682601
Treatments Being Tested